Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7951–8000 of 18431
Amanda Baldwin, pursuant to which Ms. Baldwin and the Company have agreed that she will join the Company as Chief Executive Officer, effective on a date to be determined between November 27, 2023 and January 8, 2024.
Michael Graham, who previously announced his planned retirement from the Company.
On October 12, 2023, Reynolds Consumer Products Inc. (the “Company”) announced that its Board of Directors has appointed Scott E. Huckins as the Company’s Chief Financial Officer, effective November 13, 2023
Daniel Wong ceased to be Chief Executive Officer, Chief Financial Officer and director
Effective as of October 6, 2023, Jolie Kahn resigned as Chief Financial Officer of GlucoTrack, Inc. (the “Company”) to pursue other career interests.
On October 11, 2023, the Company appointed James S Cardwell, 63, as Chief Financial Officer of the Company, effective immediately.
Upon Ms. Caixia Zhang’s appointment, Mr. Yu Yang will automatically resign as the Company’s Chief Financial Officer.
appointed Ms. Caixia Zhang as the Company’s Chief Financial Officer
On October 10, 2023, the board of directors of the Company appointed Mr. Scott Contino as Interim Chief Financial Officer.
On October 5, 2023, Ms. Ann Anthony gave notice of her intention to resign as Chief Financial Officer ("CFO") of OPAL Fuels Inc. (the “Company”) to pursue another professional opportunity.
As part of a multi-year succession plan, the Company expects that Mr. Broussard will step down as Chief Executive Officer in the latter half of 2024 and that Mr. Rechtin would become President and Chief Executive Officer at that time.
After the Effective Time, Stanley Mbugua, the Company’s Chief Accounting Officer who has served as the Interim Chief Financial Officer since August 1, 2023 will no longer serve in such capacity and will continue to serve as the Company’s Chief Accounting Officer.
On October 9 , 2023, the Board of Directors (the “Board”) of Presto appointed Nathan Cook to serve as Interim Chief Financial Officer
On October 4, 2023, James Doss, the Company’s Chief Financial Officer (“CFO”) notified the Company that he will be resigning as the CFO and principal financial officer of the Company for personal reasons, effective November 20, 2023.
Joanne Merrill was appointed Chief Financial Officer
Cecil D. Magpuri was appointed Chief Executive Officer
On October 9, 2023, Mr. Ohri and Mr. Robinson were appointed as the Company’s Co-Chief Executive Officers, effective immediately.
On October 6, 2023, Mr. Michael Franklin, Chief Executive Officer of Whole Earth Brands, Inc. (the “Company”), resigned from his position as Chief Executive Officer of the Company, effective immediately.
On October 9, 2023, Mr. Ohri and Mr. Robinson were appointed as the Company’s Co-Chief Executive Officers, effective immediately.
Sandip Kapadia and Christian Ulrich , the Chief Executive Officer and Secretary, respectively, of Purchaser immediately prior to the Effective Time, became the (i) President, Chief Executive Officer and Chief Financial Officer and (ii) Secretary, respectively, of the Surviving Corporation.
the Board of Directors (the “Board”) of Walgreens Boots Alliance, Inc. (the “Company”) appointed Timothy Charles Wentworth as Chief Executive Officer (“CEO”) of the Company, effective as of October 23, 2023
the Board of Directors (the "Board") of Sherwin-Williams elected Heidi G. Petz, age 48, to serve as Chief Executive Officer of Sherwin-Williams, effective January 1, 2024.
On October 11, 2023, Ally Financial Inc. (“Ally”) announced that Jeffrey J. Brown had provided notice of his intent to retire as Chief Executive Officer and a member of Ally’s Board of Directors (“Board”) on January 31, 2024, or an earlier date identified in writing by the Chair of the Board (the earlier of these dates, “Agreed Retirement Date”).
On October 4, 2023, Mr. Sook Keng Yeoh, the Chief Executive Officer and a member of the Board of Directors, tendered his resignation letter to Bionexus Gene Lab Corp. (the “Company”) from his positions at the Company.
On October 4, 2023, Kimberly Benson, the interim Chief Financial Officer and interim principal accounting officer of Crimson Wine Group, Ltd. (the “Company”), notified the Company that she is resigning from her position in order to pursue another business opportunity.
appointed Jay Jennings, the Company’s Chief Accounting Officer (which role did not make Mr. Jennings the principal accounting officer of the Company as Mr. Beck has previously served as both the principal financial officer and the principal accounting officer), to replace Mr. Beck as the Chief Financial Officer of the Company, effective immediately
On October 5, 2023, the Board appointed Martin Beck, the Company’s Chief Financial Officer, to serve as the Chief Executive Officer of the Company effective upon the termination of Mr. Meckey as Chief Executive Officer.
the Board determined that Mr. Beck would no longer serve as the Company’s Chief Financial Officer
On October 6, 2023, UpHealth, Inc. (the “Company”) notified Samuel J. Meckey that pursuant to a decision made by t he Board of Directors (the “Board”) on October 5, 2023, his service as the Chief Executive Officer of the Company was terminated, effective immediately
Mr. Gafford will continue to serve as the Company’s Executive Vice President and Chief Financial Officer until October 30, 2023.
Carl Schweihs, currently Executive Vice President and President of the Company’s PeopleManagement Division, will become Executive Vice President and Chief Financial Officer of the Company, succeeding Derrek Gafford, effective October 30, 2023.
Mr. Michael A. Farlekas agreed that Mr. Farlekas would depart the Company as an employee and cease serving as its Chief Executive Officer (“CEO”) and on its board of directors (the “Board”).
The Board has appointed Mr. Andrew Appel as interim CEO (“Interim CEO”) and a director of the Company.
The Board of Directors of Integer Holdings Corporation (the “Company”) has appointed Diron Smith, who currently serves as the Company’s Vice President and Interim Chief Financial Officer, as the Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective October 9, 2023.
On October 5, 2023 the Board of Directors and the Compensation Committee of Trex Company, Inc. (Company) appointed Brenda Lovcik to serve as the Company’s Senior Vice President and Chief Financial Officer effective October 23, 2023.
On October 6, 2023, the Board of Directors (the “Board”) of Aeglea BioTherapeutics, Inc. (the “Company”) appointed Dr. Cameron Turtle, the Company’s Chief Operating Officer, as the principal executive officer of the Company, effective as of the same day.
approved a leadership transition appointing Kristin Yarema, Ph.D., as President and Chief Executive Officer of the Company.
On October 9, 2023, the Company announced that John Riccitiello will retire as the Company’s President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective immediately.
On October 9, 2023, the Company announced the appointment of James Whitehurst, age 55, to serve as the Company’s Interim Chief Executive Officer and President and as a member of the Board, effective immediately.
On October 6, 2023, Derrick Sung, Ph.D., Chief Financial Officer of the Company, stepped down from his position, effective October 10, 2023 (the “ Effective Date ”), to pursue a new business opportunity.
John McKune, Vice President, Corporate Controller of the Company, was appointed by the Board of Directors of the Company (the “ Board ”) to serve as the Interim Chief Financial Officer of the Company, effective as of the Effective Date.
Giacomo Dall'Aglio was removed as the Company's Chief Financial Officer
Danilo Roncasaglia was appointed as Chief Financial Officer of the Company
Mauro Carobene was appointed as Chief Executive Officer of the Company
Effective as of October 4, 2023, Jon Garfield resigned as Chief Financial Officer of the Company.
appointed Dr. Neil Campbell, 63, as President and Chief Executive Officer of the Company and as a member of the Board of Directors
On October 9, 2023, the Board also approved the termination without cause of Dennis Bertolotti as the Company’s President and Chief Executive Officer, effective immediately.
the Board appointed Mr. Stamatakis to serve as interim President and Chief Executive Officer until a permanent President and Chief Executive Officer has been appointed.
appointed Neil F. McFarlane to serve as the Company’s President and Chief Executive Officer, effective October 10, 2023
Andrew Trumbach, the Company’s current President and a director, was reappointed as Chief Financial Officer of the Company to replace Mr. Vasquez.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.